Artificial chordae for mitral valve repair

J Card Surg. 2022 Nov;37(11):3722-3728. doi: 10.1111/jocs.16937. Epub 2022 Sep 18.

Abstract

Background: Mitral valve repair using expanded polytetrafluoroethylene sutures to replace mitral chordae tendineae is a well-established procedure. However, the incidence of neo-chordae failure causing recurrent mitral regurgitation is not well defined.

Methods: We have reviewed the reported cases of complications after mitral valve repair related to the use of neo-chordae. This study was mainly carried out through PubMed, Medline, and Google Chrome websites.

Results: We have identified a total of 26 patients presenting with rupture of polytetrafluoroethylene neo-chordae, mostly being described as isolated cases. Few other cases of recurrent mitral regurgitation with hemolysis were found, where reoperation was not caused by neo-chordal failure but most likely by technical errors. At pathological investigation the findings were substantially similar in all reported cases. The neo-chordae retained their length and pliability, became covered with host tissue and rupture was mainly related to suture size. Mild calcification was observed not interfering with chordal function; chordal infection did never occur.

Conclusions: The use of artificial neo-chordae provides excellent late results with durable mitral valve repair stability. Chordal rupture may occur late postoperatively leading to reoperation because of recurrent mitral regurgitation. Despite its rarity, this potential complication should not be overlooked during follow-up of patients after mitral valve repair using artificial neo-chordae.

Keywords: cardiovascular pathology; valve repair/replacement.

Publication types

  • Review

MeSH terms

  • Chordae Tendineae / pathology
  • Chordae Tendineae / surgery
  • Humans
  • Mitral Valve / pathology
  • Mitral Valve / surgery
  • Mitral Valve Insufficiency*
  • Mitral Valve Prolapse* / surgery
  • Polytetrafluoroethylene
  • Sutures

Substances

  • Polytetrafluoroethylene